Most Clicked StoriesMore >


Formulary exclusions do not lead to non-adherence

PCMA SmartBrief | Aug 19, 2014

Data from pharmacy benefit managers that have ruled out certain drugs from formularies show no significant correlation between exclusions and patient non-adherence to prescription regimens. Pink Sheet (subscription required), The (08/15)


Report implicates pharmacies in rampant Medicare drug fraud

PCMA SmartBrief | Aug 18, 2014

FDA tentatively approves biosimilar insulin

PCMA SmartBrief | Aug 19, 2014

Some big companies plan to offer skinny health plans

PCMA SmartBrief | Aug 14, 2014

Insurers battle compounding industry profiteering

PCMA SmartBrief | Aug 15, 2014

FDA's draft biosimilarity guidance criticized by industry

PCMA SmartBrief | Aug 18, 2014

Budget-busting "any willing pharmacy" rule in Medicare Part D is bad for consumers

PCMA SmartBrief | Aug 15, 2014

Hospital systems' payment assistance raises legal concerns

PCMA SmartBrief | Aug 14, 2014

Access to Sovaldi may be limited for patients getting opioid treatment

PCMA SmartBrief | Aug 14, 2014

PCMA supports House efforts to fight drug fraud in Medicare Part D

PCMA SmartBrief | Aug 15, 2014


Find PCMA SmartBrief Issues by Date:





Sign up for PCMA SmartBrief



Designed specifically for PBM industry professionals, PCMA SmartBrief is a FREE, daily e-mail newsletter. It provides the the most relevant and actionable PBM industry news in a quick, easy to read format. Learn more